1. Home
  2. AFYA vs UPB Comparison

AFYA vs UPB Comparison

Compare AFYA & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • UPB
  • Stock Information
  • Founded
  • AFYA 1999
  • UPB 2021
  • Country
  • AFYA Brazil
  • UPB United States
  • Employees
  • AFYA N/A
  • UPB N/A
  • Industry
  • AFYA Other Consumer Services
  • UPB
  • Sector
  • AFYA Real Estate
  • UPB
  • Exchange
  • AFYA Nasdaq
  • UPB NYSE
  • Market Cap
  • AFYA 1.6B
  • UPB 1.3B
  • IPO Year
  • AFYA 2019
  • UPB 2024
  • Fundamental
  • Price
  • AFYA $16.26
  • UPB $17.80
  • Analyst Decision
  • AFYA Hold
  • UPB Strong Buy
  • Analyst Count
  • AFYA 4
  • UPB 4
  • Target Price
  • AFYA $21.13
  • UPB $56.50
  • AVG Volume (30 Days)
  • AFYA 120.1K
  • UPB 252.2K
  • Earning Date
  • AFYA 11-13-2024
  • UPB 11-07-2024
  • Dividend Yield
  • AFYA N/A
  • UPB N/A
  • EPS Growth
  • AFYA 61.94
  • UPB N/A
  • EPS
  • AFYA 1.17
  • UPB N/A
  • Revenue
  • AFYA $584,951,886.00
  • UPB $2,207,000.00
  • Revenue This Year
  • AFYA $19.06
  • UPB N/A
  • Revenue Next Year
  • AFYA $11.30
  • UPB N/A
  • P/E Ratio
  • AFYA $13.98
  • UPB N/A
  • Revenue Growth
  • AFYA 16.67
  • UPB 82.10
  • 52 Week Low
  • AFYA $15.52
  • UPB $17.09
  • 52 Week High
  • AFYA $22.48
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 41.44
  • UPB N/A
  • Support Level
  • AFYA $15.52
  • UPB N/A
  • Resistance Level
  • AFYA $16.60
  • UPB N/A
  • Average True Range (ATR)
  • AFYA 0.54
  • UPB 0.00
  • MACD
  • AFYA -0.15
  • UPB 0.00
  • Stochastic Oscillator
  • AFYA 25.52
  • UPB 0.00

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.

Share on Social Networks: